(What is heart_disease? - Edit Wiki)
Videos 1 to 30
 #14: Heart of Health - installment #3
from That's Good Medicine
November 10, 2008
Heart of Health - do you have one? Helen Keller: The heresy of one age becomes the orthodoxy of the next.” Is it time to quit viewing EDTA chelation therapy for heart disease as medical heresy, and start using on a more wide spread basis in this new age of medicine? This is Part 2 of Effective Alternatives for Treating Cardiovascular Disease – EDTA Chelation as Front-Runner. Trial to Assess Chelation Therapy, TACT trial: We discuss this placebo-controlled trial sponsored by the National Institute of Health. This research is worthwhile, but in our opinion we already have enough empirical and research-based evidence to be offering intravenous EDTA chelation therapy to cardiovascular disease patients now. Regardless, and unfortunately, it appears that the so-called quack busters - the phony experts from the National Council Against Health Fraud - are trying to sabotage the TACT trial in attempt to expunge this safe, simple, effective and inexpensive alternative treatment for cardiovascular diseases. Next week we shine the TGM spotlight on the quack busters. EDTA Monograph by Cardiologist Dr. Stephen Olmstead: The preponderance of clinical reports in the medical literature support a claim of efficacy for symptomatic angina, intermittent claudication and critical leg ischemia.” Note: we are currently trying to get in touch with Dr. Olmstead to find a digital version of the Monograph and link to it from the TGM website. EDTA Chelation Therapy as Holistic Therapy: EDTA is not a natural product. It is an artificial, synthetic drug. However, one could argue that it is a holistic therapy since it is infused systemically, and reaches and potentially detoxifies heavy metals from most of our tissues and organs. EDTA Package Insert Altered by Abbott Labs to Remove Cardiovascular Disease as an Indication for the Drug: Even by the 1960s existing evidence for EDTAs efficacy to treat cardiovascular disease was enough for Abbott Labs to include it as one of the indications for the drug. Later the language was arbitrarily changed, stating that EDTA is not indicated for this purpose. To the best of our knowledge, this mysterious manipulation of medical product information is unprecedented in medical history. Off-Label Drug Legislation the Result of One Doctor’s Fight Against the FDA to Be Able to Offer EDTA Chelation to His Patients. In 1981, during a David and Goliath type battle, Dr. Ray Evers from Alabama fought the US Food and Drug Administration for his right to use EDTA to treat his patients with cardiovascular disease. With EDTA in his sling he toppled the FDA. The federal court ruling in favor of Dr. Evers stated that the FDA’s arguments against Dr. Evers were “nonsensical.” This was a huge victory for patients and the advancement of good medicine not only because it lessened the FDA s tyranny against our medical freedoms, but also because it resulted in today s doctors ability to prescribe drugs ‘off-label.’ This means we can now legally use any medication for any purpose, even though that purpose – that ‘indication’ – is not necessarily approved by the FDA. All this because of Dr. Ever s fight for EDTA! Kevin asks the logical question: Why was the FDA trying to regulate an Alabama doctor s medical practice? And Dr. Douglass asks: What political influences – what constituencies/vested interests – may have teamed up with the FDA to start that battle against EDTA and Dr. Evers in the first place? We ll may never know. Dr. Rogers vs. the Florida State Board of Medical Examiners: Dr. Robert Rogers, MD fought the Florida Medical Board all the way to the Florida Supreme Court over his right to provide EDTA to his patients with cardiovascular disease, and won. The Florida Supreme Court ruled that the action of the Florida medical board restraining Dr. Rogers from utilization of chelation therapy for his patients was “an arbitrary and unreasonable exercise of the state’s police power.” Negative Published Studies On EDTA Chelation Therapy For Treating Cardiovascular Disease: There have been six negative studies. We discuss them, and how they all either have major irregularities from a scientific standpoint, or have negative conclusions even though the results reported in the studies were positive. For an excellent online resource with commentary and analysis of each one of the studies, go to http://www.drcranton.com/chelation.htm And as we ve mentioned on previous shows, a good resource for finding physicians who are likely to be offering intravenous EDTA is the organization American College for Advancement in Medicine at acam.org. Good Medicine Word Of The Week: Off-label use - in commemoration of Dr. Ray Evers and his David and Goliath fight against the FDA. Now American physicians can use EDTA, and any other drugs, for purposes other than what the FDA approves them for. Next week: If intravenous EDTA chelation really is a safe, effective and inexpensive alternative to bypass surgery and angioplasty, do you think there might be attempts by conventional medicine to squelch it? We ll shine the TGM spotlight on the phoney quack busters and the so-called National Councel Against Health Fraud (or is it the National Councel of Health Frauds ?) in their obvious efforts to supress the TACT trial and our access to EDTA chelation therapy for treating heart disease.
|
 Bioheart Interview
from recent posts - blip.tv (beta)
October 01, 2008
Bioheart, Inc. (Nasdaq: BHRT) is committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to improve a patient's quality of life and reduce health care costs and hospitalizations. Specific to biotechnology, Bioheart is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate, MyoCell(R), is an innovative clinical muscle-derived stem cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients. The Company's pipeline includes multiple product candidates for the treatment of heart damage, including Bioheart Acute Cell Therapy, an autologous, adipose tissue-derived stem cell treatment for acute heart damage, and MyoCell(R) SDF-1, a therapy utilizing autologous cells that are genetically modified to express additional potentially therapeutic growth proteins.5BB1797B-528C-1833-051D-45B902DE288E1.02.05
|
 Health Report 2008-09-08
from Health Report
September 07, 2008
Depression and heart attack Depression and heart disease are two leading disorders which add to the global burden of disease. Several large-scale studies have investigated whether treatment of depression improves prognosis after heart attack. Homicide by the mentally ill - a rare event A study recently published in the British Journal of Psychiatry showed that the rate of homicide due to mentall illness has fallen steadily after the late 1970s. According to this study the risk of lethal violence by a person with schizophrenia who has received adequate treatment is not much higher than the community as a whole and the period of greatest risk is before initial treatment. Getting psychiatrists to the people who need them According to general practitioners and other health professionals, it is often difficult to get expert psychiatric help needed for a patient. In the Canadian province of Ontario they've developed a program to overcome this problem.
|
Health Report 2008-07-07
from Health Report
July 06, 2008
CT angiography - a test for heart disease This type of CT scan enables doctors to obtain quite detailed pictures of the coronary arteries. However, American experts are questioning its value and they're supported in this by the American Heart Association. Genetic screening test for Stickler syndrome Stickler syndrome is a genetic abnormality that can cause life-threatening spinal conditions, premature arthritis, blindness and deafness. A genetic screening test which was developed by researchers at the Murdoch Children's Research Institute in Melbourne, will now be offered to Victorians for free. Huntington's disease Huntington's disease is an inherited neurodegenerative disease that causes certain nerve cells in the brain to waste away. People are born with the disease and there is no cure. Researchers in the U.S. are investigating new treatment methods for patients who suffer from the disease.
|
 ROUTINE CARDIAC CATHETERIZATION BENEFITS SOME WOMEN WITH HEART DISEASE MORE THAN OTHERS
from flashhbr
July 02, 2008
Heart disease is the number one killer of women each year in the United States. Cardiac catheterization is a routine procedure that allows doctors to find potential blockages in coronary arteries in order to help prevent new heart attacks and even death. A recent study finds that high risk women, who do have a heart attack, benefit from this procedure just as much as men. But for some women the procedure may not always be the best option.
|
 Heart Medicine Gene
from ScienCentral News: Making Sense of Science
June 30, 2008
Genetics researchers have debunked a racial myth about who might benefit from a widely used heart failure medication. As this ScienCentral video reports, the finding will eventually allow personalized treatments for this devastating disease.
|
|
Log in or sign up to leave comments.
0 comments on heart disease:
(No comments yet..)
get widgets
RSS feed for heart disease: 
To add your video to this page, just add this code in your video blog post:
|
